company background image
1752 logo

Nang Kuang Pharmaceutical TWSE:1752 Stock Report

Last Price

NT$47.15

Market Cap

NT$4.7b

7D

1.3%

1Y

-20.2%

Updated

27 Mar, 2024

Data

Company Financials

Nang Kuang Pharmaceutical Co., Ltd.

TWSE:1752 Stock Report

Market Cap: NT$4.7b

1752 Stock Overview

Nang Kuang Pharmaceutical Co., Ltd. engages in the manufacturing, processing, trading, import, and export of pharmaceuticals and medical devices in Taiwan and internationally.

1752 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Nang Kuang Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nang Kuang Pharmaceutical
Historical stock prices
Current Share PriceNT$47.15
52 Week HighNT$85.70
52 Week LowNT$45.60
Beta0.28
1 Month Change-6.08%
3 Month Change-11.21%
1 Year Change-20.22%
3 Year Change18.92%
5 Year Change56.38%
Change since IPO178.26%

Recent News & Updates

Recent updates

Nang Kuang Pharmaceutical (GTSM:1752) Has A Pretty Healthy Balance Sheet

Mar 20
Nang Kuang Pharmaceutical (GTSM:1752) Has A Pretty Healthy Balance Sheet

Should You Or Shouldn't You: A Dividend Analysis on Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Mar 03
Should You Or Shouldn't You: A Dividend Analysis on Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Declining Stock and Decent Financials: Is The Market Wrong About Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)?

Feb 13
Declining Stock and Decent Financials: Is The Market Wrong About Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)?

Nang Kuang Pharmaceutical's (GTSM:1752) Stock Price Has Reduced 17% In The Past Five Years

Jan 26
Nang Kuang Pharmaceutical's (GTSM:1752) Stock Price Has Reduced 17% In The Past Five Years

Estimating The Fair Value Of Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Jan 08
Estimating The Fair Value Of Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Here's How We Evaluate Nang Kuang Pharmaceutical Co., Ltd.'s (GTSM:1752) Dividend

Nov 29
Here's How We Evaluate Nang Kuang Pharmaceutical Co., Ltd.'s (GTSM:1752) Dividend

Shareholder Returns

1752TW PharmaceuticalsTW Market
7D1.3%1.7%1.1%
1Y-20.2%5.9%26.7%

Return vs Industry: 1752 underperformed the TW Pharmaceuticals industry which returned 5.9% over the past year.

Return vs Market: 1752 underperformed the TW Market which returned 26.7% over the past year.

Price Volatility

Is 1752's price volatile compared to industry and market?
1752 volatility
1752 Average Weekly Movement2.4%
Pharmaceuticals Industry Average Movement3.9%
Market Average Movement4.2%
10% most volatile stocks in TW Market7.9%
10% least volatile stocks in TW Market1.9%

Stable Share Price: 1752 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1752's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1963n/aYu-Bei Wanghttps://www.nangkuang.com.tw

Nang Kuang Pharmaceutical Co., Ltd. engages in the manufacturing, processing, trading, import, and export of pharmaceuticals and medical devices in Taiwan and internationally. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It also offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solutions.

Nang Kuang Pharmaceutical Co., Ltd. Fundamentals Summary

How do Nang Kuang Pharmaceutical's earnings and revenue compare to its market cap?
1752 fundamental statistics
Market capNT$4.68b
Earnings (TTM)NT$394.97m
Revenue (TTM)NT$2.23b

12.1x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1752 income statement (TTM)
RevenueNT$2.23b
Cost of RevenueNT$1.44b
Gross ProfitNT$795.69m
Other ExpensesNT$400.71m
EarningsNT$394.97m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)3.91
Gross Margin35.60%
Net Profit Margin17.67%
Debt/Equity Ratio24.9%

How did 1752 perform over the long term?

See historical performance and comparison

Dividends

4.9%

Current Dividend Yield

59%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.